“The home healthcare equipment and services market is slated to grow at 6% to 8% year on year for the next five years. The market is estimated to reach $345 bn by 2020.
The demand for home healthcare services is growing at a steady pace across the globe. Increasing costs of in-hospital care and the comfort of convalescing at home are making home healthcare affordable and desirable in both developed and developing nations alike. Better and cheaper medical devices have moved the diagnosis of various ailments from hospitals to the living room.
Increasingly, people suffering from chronic ailments such as cardiovascular diseases, cancer, respiratory diseases and diabetes prefer home healthcare services. The services for geriatric ailments, physical, occupational and speech therapies, and personal care are rapidly becoming a necessity more than luxury. Currently, over 70% of those using home healthcare services belong to the age group of 65-75 years or older. The World Bank estimates that by 2050, close to 21% of the world population will be over 60 years old, making home healthcare a key sector to be followed.
The market in Asia for healthcare equipment alone is set to grow from $3bn currently to $11 bn by 2016. This presents a huge growth opportunity for Home Healthcare providers who are looking for opportunities in countries other than the U.S where the growth is almost stable, but tied to reimbursements from Medicare and Medicaid policies. Developing countries like India are the high-growth regions ripe for capture. Many players have already started cashing in on this opportunity. The US-based BAYADA Home Healthcare has recently acquired a 26% stake in India-based Indian Home Healthcare (IHHC).
The home healthcare market is an aggregate of home health products and services. Awareness about the convenience and cost effectiveness offered by these products and services is also increasing the demand for this market. Advanced Economies also maintain a stable growth mainly due to reimbursements offered for specific equipment and health policies of government and private entities. Portability, customization, ease of use, and automation are the key factors that home healthcare market players use to differentiate their products and services.
Competitive landscape for each of the product types is highlighted and market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of the key players for 2012 are provided.
The prominent players profiled in this report are:
Baxter,
Bayer,
GE Healthcare,
Philips and others.
The report contains the most detailed and in-depth segmentation of the global home healthcare market.”
“1. Global Home Healthcare – Market Overview
2. Executive Summary
3. Global Home Healthcare – Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End user profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financials Analysis
4. Global Home Healthcare – Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Home Healthcare Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Global Home Healthcare Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Product / Equipment Suppliers and Distributors
6. Home Healthcare Services Market
6.1. Rehabilitation Services
6.1.1. Occupational Therapy
6.1.2. Physical Therapy
6.1.3. Speech & Language Pathologists
6.2. Skilled Care / Nursing
6.2.1. Wound Care
6.2.2. Diabetic Care
6.2.3. Cardiac & Respiratory Assessment
6.2.4. Pain Management
6.2.5. IV therapy
6.2.6. Cancer Care
6.2.7. Others
6.3. Unskilled Care & Respite Care
6.3.1. Domestic
6.3.2. Personal
6.3.3. Others
6.4. Technological
6.4.1. Virtual / Remote / Telehealth
6.5. Hospice Care
6.6. Companion Care
6.7. Infusion Services
6.8. Medical – Social Working Services
6.9. Others
6.9.1. Nutritional
6.9.2. Visually Impaired
6.9.3. Respiratory Therapy
7. Home Healthcare Market – By Type of Aliment / Disease / Problem
7.1. Chronic Obstructive Pulmonary Disease
7.2. Diabetes
7.3. Hypertension
7.4. Smoking
7.5. Asthma
7.6. Depression
7.7. Heart
7.7.1. congestive Heart Failure (CHF) Management
7.7.2. Chronic Ischemic Heart Disease (CIHD)
7.7.3. Other Heart Diseases
7.8. Dementia / Alzheimer’s disease (AD)
7.9. Obesity
7.10.Parkinson’s disease
7.11.Coronary Artery Disease
7.12.Infectious Diseases
7.12.1. HIV/AIDS
7.13.Bone & Joint Diseases
7.14.Cardiovascular & Metabolic Diseases
7.15.Others
8. Home Healthcare Products / Equipment Market
8.1. Dialysis Products
8.1.1. Continuous
8.1.2. Automated
8.2. Diabetes Care Products
8.3. Drug Delivery Devices
8.3.1. Pumps
8.3.2. Syringes
8.4. Essential / Medical Aid Equipment
8.4.1. Hospital Beds
8.4.2. Wheelchairs
8.4.3. Ambulatory Aids
8.4.4. Commodes
8.4.5. Bathroom Safety
8.4.6. Patient Lifts
8.4.7. Incontinence Supplies
8.4.8. Urinary Supplies
8.4.9. Others
8.5. Pregnancy Tests
8.6. Respiratory Equipment
8.6.1. Mechanical Ventilators
8.6.2. Oxygen Therapy Equipment
8.6.3. Nebulizers
8.6.4. Obstructive Sleep Apnea Products
8.6.5. Portable E Tanks
8.6.6. Others
8.7. Mobility Products
8.7.1. Canes
8.7.2. Crutches
8.7.3. Ramps
8.7.4. Walkers
8.7.5. Patient Lifts
8.8. Wound Care Products
8.9. Others
9. Geographic Analysis
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.2. Latin America
9.2.1. Brazil
9.2.2. Mexico
9.3. Europe
9.3.1. UK
9.3.2. Germany
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Russia
9.3.7. Rest Of Europe
9.4. Asia
9.4.1. India
9.4.2. China
9.4.3. Japan
9.4.4. Korea
9.5. Rest of the World
10. Market Entropy
10.1. New Product Launches
10.2. M&As, Collaborations, JVs and Partnerships
11. Investment Opportunities – Analysis by Target companies/customers, Capital Investments, ROI, Payback Period and Source of Funds.
12. Company Profile (Company Overview, Product and Services, Strategy, Developments, USP)
12.1. A&D COMPANY, LTD.
12.2. APRIA HEALTHCARE GROUP, INC.
12.3. ABBOTT LABORATORIES
12.4. ALERE, INC.
12.5. ALMOST FAMILY, INC.
12.6. BAXTER INTERNATIONAL, INC.
12.7. B. BRAUN MELSUNGEN AG.
12.8. BAYER AG
12.9. C.R BARD
12.10. COVIDIEN LTD.
12.11. FRESENIUS SE & CO KGAA
12.12. Fisher & Paykel Healthcare
12.13. GE HEALTHCARE
12.14. GENTIVA HEALTH SERVICES INC.
12.15. ICON HEALTH & FITNESS, INC.
12.16. I-FlOW
12.17. INVACARE
12.18. JOHNSON & JOHNSON
12.19. KINETIC CONCEPTS, INC.
12.20. LHC GROUP, INC.
12.21. LINDE GROUP
12.22. OMRON HEALTHCARE CO., LTD.
12.23. NESTLE S.A.
12.24. PHILIPS HEALTHCARE
12.25. CARDINAL HEALTH, INC.
12.26. PHOTOMEDEX, INC.
12.27. ROCHE HOLDING AG
12.28. RES MED
12.29. SMITHS GROUP PLC
12.30. SUNRISE MEDICAL
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
“”*Financials would be provided on a best efforts basis for private companies””
13. Appendix
13.1. Abbreviations
13.2. Sources
13.3. Research Methodology
13.4. Bibilography
13.5. Compilation of Expert Insights
13.6. Disclaimer”
“12.1. A&D COMPANY, LTD.
12.2. APRIA HEALTHCARE GROUP, INC.
12.3. ABBOTT LABORATORIES
12.4. ALERE, INC.
12.5. ALMOST FAMILY, INC.
12.6. BAXTER INTERNATIONAL, INC.
12.7. B. BRAUN MELSUNGEN AG.
12.8. BAYER AG
12.9. C.R BARD
12.10. COVIDIEN LTD.
12.11. FRESENIUS SE & CO KGAA
12.12. Fisher & Paykel Healthcare
12.13. GE HEALTHCARE
12.14. GENTIVA HEALTH SERVICES INC.
12.15. ICON HEALTH & FITNESS, INC.
12.16. I-FlOW
12.17. INVACARE
12.18. JOHNSON & JOHNSON
12.19. KINETIC CONCEPTS, INC.
12.20. LHC GROUP, INC.
12.21. LINDE GROUP
12.22. OMRON HEALTHCARE CO., LTD.
12.23. NESTLE S.A.
12.24. PHILIPS HEALTHCARE
12.25. CARDINAL HEALTH, INC.
12.26. PHOTOMEDEX, INC.
12.27. ROCHE HOLDING AG
12.28. RES MED
12.29. SMITHS GROUP PLC
12.30. SUNRISE MEDICAL”
